Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-02-06 @ 1:13 AM
Study NCT ID:
NCT04865705
Status:
UNKNOWN
Last Update Posted:
2021-04-29
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung Cancer
Sponsor:
Organization: